VANCOUVER, BC, May 8, 2025 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, released its first quarter financial results and operational highlights for the period ended March 31, 2025. “This quarter we were pleased to see positive data from a clinical trial studying our botanical psilocybin…